Corindus Banner Image

Welcome to our blog!

Posted by David Handler
August 22, 2013
david.png

As the President & Chief Executive Officer of Corindus Vascular Robotics, I would like welcome you and thank you for visiting our new blog!

Through this blog, we will bring you a perspective on the latest information on medical innovations; changes in interventional cardiology and angioplasty;and opportunities to improve healthcare delivery in the United States. As the leader in robotic-assisted angioplasty we will focus our attention on the current issues that affect interventional cardiologists and their patients. On an ongoing basis, you'll hear from leading medical professionals and the insightful minds of our staff as we discuss heart disease from a variety of angles.

Heart disease is a widespread epidemic in the United States and around the world. Coronary artery disease (also known as CAD, coronary heart disease, or CHD) is the number one cause of death for men and women alike in the U.S. Oftentimes, someone suffering from CAD will need to undergo apercutaneous coronary intervention (PCI) in order to relieve a blockage in the coronary arteries.

PCI, better known as coronary angioplasty,is a lifesaving procedure performed nearly one million times per year in the United States. That means it is very likely that you, or someone you know has undergone or will need to undergo an angioplasty procedure at some point. Since the advent of coronary angioplasty in 1977 by Andreas Gruentzig, the procedure has remained largely unchanged.

Vascular-Robotic-System

Now, accomplished and respected physicians around the country are performing robotic angioplasties using our CorPath® Vascular Robotic System.

Here at Corindus Vascular Robotics, we have developed this novel robotic-assisted system to address the challenges faced in the catheterization lab during PCI procedures. The CorPath Vascular Robotic Program is designed to put the precision of robotics into the hands of heart experts. The technology our team has developed has the capability to address other segments of the vascular market in the future, including peripheral, neuro, and structural heart applications.

We believe that the application of innovative technologies such as CorPath can have a dramatic and positive impact on the treatment of diseases like CAD.

CorPath-Robotic1

CorPath Robotic-assisted System in the Cath Lab

I look forward to your feedback on our posts and to using this blog as an opportunity to let you better understand how innovation is making an impact on how we treat heart disease.

  
Download the Free Issue Brief

FOLLOW US

Link to my Twitter Page
Link to my Linkedin Page
Link to my Facebook Page
Link to my Rss Page

CORINDUS TWITTER FEED